Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01567371 · ClinicalTrials.gov registry record · NA

LiDCO Monitor Study

A NA study, sponsored by Nationwide Children's Hospital.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01567371: Completed NA study, sponsored by Nationwide Children's Hospital.

NCT01567371 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01567371, a NA study, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This is a study to validate the utility and accuracy of the non-invasive device (LiDCOrapid monitor) during a period of phlebotomy and graded blood loss in patients who are having cardiac surgery.

Primary Outcome

The difference in pulse pressure variability during a period of phlebotomy and graded blood loss, measured before phlebotomy or acute normovolemic hemodilution (ANH) and immediately after.

Interventions

  • DEVICE LiDCO rapid monitor

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2012-03
Est. Completion 2015-03
Phase NA
Nationwide Children's Hospital

188 total trials

What the finished NCT01567371 record still lists

NCT01567371 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which LiDCO rapid monitor is the first listed.

NCT01567371 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01567371 about?

NCT01567371 is a clinical study titled "LiDCO Monitor Study". This is a study to validate the utility and accuracy of the non-invasive device (LiDCOrapid monitor) during a period of phlebotomy and graded blood loss in patients who are having cardiac surgery.

What is the current status of trial NCT01567371?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-03. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01567371?

The interventions under investigation include: LiDCO rapid monitor (DEVICE).

Who is sponsoring clinical trial NCT01567371?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01567371's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01567371, the US trial registry maintained by the National Library of Medicine. NCT01567371 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.